Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
 

Treating Opioid Use Disorder: A Pharmacist's Guide for Understanding Medication Assisted Treatment (MAT)


Date: Mar 21, 2020 09:00 AM - Apr 18, 2020 01:00 PM

Location: Marriott Bonvoy, 5151 Pooks Hill Rd, Bethesda, MD, 20814

Fee

$0.00

CE Hours

6.00

CE Units

0.600

Registration closes on Apr 25, 2020 10:30 PM

Activity Type

  • Knowledge & Application

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Joint Provider(s)

The Danya Institute; MidAtlantic Aids Education and Training Center (MAAETC)

 

 

 

   

Objectives

  • Describe the epidemiology of opioid overdose and opioid use disorder in the United States
  • Examine the prescribing patterns of opioids for chronic non-cancer pain over the past two decades
  • Differentiate the clinical presentation of opioid dependence, opioid withdrawal and opioid use disorder
  • Classify the pharmacology and therapeutics for methadone, buprenorphine/naloxone, and naltrexone for the treatment of opioid use disorder
  • Identify treatment considerations for patients with HIV and Opioid Use Disorder

Speaker(s)/Author(s)

Jasmine Carpenter, PharmD, BCPS, PharmD, RPh
Mental Health Pharmacist, Veterans Affairs Medical Center

Activity Number

0010-9999-20-010-L01-P
Date: 03/21/20
Time: 09:00 AM - 01:00 PM

CE Hours

3.00

Fee

$15.00
   

 

   

Objectives

  • Describe the epidemiology of opioid overdose and opioid use disorder in the United States
  • Examine the prescribing patterns of opioids for chronic non-cancer pain over the past two decades
  • Differentiate the clinical presentation of opioid dependence, opioid withdrawal and opioid use disorder
  • Classify the pharmacology and therapeutics for methadone, buprenorphine/naloxone, and naltrexone for the treatment of opioid use disorder
  • Identify treatment considerations for patients with HIV and Opioid Use Disorder

Speaker(s)/Author(s)

Jasmine Carpenter, PharmD, BCPS, PharmD, RPh
Mental Health Pharmacist, Veterans Affairs Medical Center

Activity Number

0010-9999-20-010-L01-P
Date: 04/18/20
Time: 09:00 AM - 05:00 PM

CE Hours

3.00